These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32660480)

  • 21. Drug substitution associated with a hospital stay in Belgium: a retrospective analysis of a claims database.
    Simoens S; Dubois C; Spinewine A; Foulon V; Paulus D
    Int J Pharm Pract; 2014 Apr; 22(2):105-11. PubMed ID: 23829345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.
    Kesselheim AS; Bykov K; Gagne JJ; Wang SV; Choudhry NK
    Neurology; 2016 Oct; 87(17):1796-1801. PubMed ID: 27683844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brand-to-generic oxcarbazepine switch - A prospective observational study.
    Bosak M; Słowik A; Dziedzic T
    Epilepsy Res; 2019 Mar; 151():75-77. PubMed ID: 30836239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia.
    Kalisch LM; Roughead EE; Gilbert AL
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):620-5. PubMed ID: 18324613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes].
    Izumi T; Hori S; Satoh H; Miki A; Sawada Y
    Yakugaku Zasshi; 2012; 132(5):617-27. PubMed ID: 22687698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generic substitution of antihypertensive drugs: does it affect adherence?
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Ann Pharmacother; 2006 Jan; 40(1):15-20. PubMed ID: 16303985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Generic substitution in primary care in 2011: differences according to pharmacological classes?].
    Sommet A; Georgel B; Poutrain JC; Oustric S; Bourrel R; Montastruc JL; Birebent J
    Rev Epidemiol Sante Publique; 2013 Dec; 61(6):539-44. PubMed ID: 24211149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
    Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
    JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
    Layton S; Barbeau M
    Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generic and therapeutic statin switches and disruptions in therapy.
    Chapman RH; Benner JS; Girase P; Benigno M; Axelsen K; Liu LZ; Nichol MB
    Curr Med Res Opin; 2009 May; 25(5):1247-60. PubMed ID: 19344292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact on health outcomes and healthcare utilisation of switching to generic medicines consequent to reference pricing: the case of lamotrigine in New Zealand.
    Lessing C; Ashton T; Davis P
    Appl Health Econ Health Policy; 2014 Oct; 12(5):537-46. PubMed ID: 25005492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study.
    Lim YC; Lee EK; Park MH
    Lipids Health Dis; 2023 Sep; 22(1):151. PubMed ID: 37705044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based study.
    Corrao G; Soranna D; Merlino L; Mancia G
    Eur J Clin Invest; 2014 Oct; 44(10):933-9. PubMed ID: 25132063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.
    Sacks CA; Lee CC; Kesselheim AS; Avorn J
    JAMA; 2018 Aug; 320(7):650-656. PubMed ID: 30140875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing the use of the "not for generic substitution" mention for prescriptions in primary care: a survey with general practitioners.
    Beauvais V; Marque A; Ferté G; Chrusciel J; Souille J; Nazeyrollas P; Sanchez S
    BMC Health Serv Res; 2018 Nov; 18(1):850. PubMed ID: 30419890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generic substitution of antidiabetic drugs in the elderly does not affect adherence.
    Trotta F; Da Cas R; Maggini M; Rossi M; Traversa G
    Ann Ist Super Sanita; 2014; 50(4):333-40. PubMed ID: 25522073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G
    Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of the cost and effectiveness of generic and brand-name antibiotics: the case of uncomplicated urinary tract infection.
    Lin YS; Jan IS; Cheng SH
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):301-309. PubMed ID: 27862588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan.
    Hsu CW; Lee SY; Wang LJ
    Schizophr Res; 2018 Mar; 193():107-113. PubMed ID: 28629889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.